Drug industry gives up legal battle over new UK cost curbs
By Ben Hirschler LONDON (Reuters) – Britain’s pharmaceuticals industry has thrown in the towel in a legal battle over new cost curbs imposed by the state-run health service, after failing to secure a judicial review. Drugmakers argue the curbs, imposed earlier this year, have the potential to cause significant delays for patients waiting for treatment […]
Read More